Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
2.270
-0.150 (-6.20%)
At close: Jun 18, 2026, 4:00 PM EDT
2.300
+0.030 (1.32%)
After-hours: Jun 18, 2026, 7:18 PM EDT
Ovid Therapeutics Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Ovid Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $5.47. The average 1-year stock price forecast is 140.97% higher than the current stock price, while the lowest is $4.00 (+76.21%) and the highest is $7.00 (+208.37%).
Price Target: $5.47 (+140.97%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Ovid Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 11 | 11 | 10 | 10 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $4 | Buy | Reiterates | $4 | +76.21% | Jun 8, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $5 | Buy | Maintains | $5 | +120.26% | May 16, 2026 |
| Roth MKM | Roth MKM | Buy Reiterates $7 | Buy | Reiterates | $7 | +208.37% | May 14, 2026 |
Unknown Analyst B. Riley Securities No rating | B. Riley Securities | Buy Reiterates $5 | Buy | Reiterates | $5 | +120.26% | May 13, 2026 |
| Wedbush | Wedbush | Buy Maintains $7 | Buy | Maintains | $7 | +208.37% | May 13, 2026 |
Financial Forecast
Revenue This Year
107.50K
from 7.25M
Decreased by -98.52%
Revenue Next Year
166.67K
from 107.50K
Increased by 55.04%
EPS This Year
-0.44
from -0.23
EPS Next Year
-0.45
from -0.44
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 850,000 | ||
| Avg | 107,500 | ||
| Low | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -88.3% | ||
| Avg | -98.5% | ||
| Low | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | -0.44 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |